GB0428327D0 - Method - Google Patents

Method

Info

Publication number
GB0428327D0
GB0428327D0 GB0428327A GB0428327A GB0428327D0 GB 0428327 D0 GB0428327 D0 GB 0428327D0 GB 0428327 A GB0428327 A GB 0428327A GB 0428327 A GB0428327 A GB 0428327A GB 0428327 D0 GB0428327 D0 GB 0428327D0
Authority
GB
United Kingdom
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0428327A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GB0428327A priority Critical patent/GB0428327D0/en
Publication of GB0428327D0 publication Critical patent/GB0428327D0/en
Priority to KR1020077016875A priority patent/KR20070091677A/en
Priority to PCT/GB2005/004895 priority patent/WO2006067401A1/en
Priority to MX2007007428A priority patent/MX2007007428A/en
Priority to CA2589748A priority patent/CA2589748C/en
Priority to AU2005317928A priority patent/AU2005317928B2/en
Priority to UAA200706266A priority patent/UA93489C2/en
Priority to US11/793,606 priority patent/US7906645B2/en
Priority to EP05820651A priority patent/EP1831164A1/en
Priority to RU2007130144/04A priority patent/RU2423349C2/en
Priority to JP2007547621A priority patent/JP5118975B2/en
Priority to NZ555770A priority patent/NZ555770A/en
Priority to BRPI0519288-9A priority patent/BRPI0519288A2/en
Priority to CN200580048668.2A priority patent/CN101128427B/en
Priority to MYPI20056171A priority patent/MY147400A/en
Priority to UY29312A priority patent/UY29312A1/en
Priority to TW094146424A priority patent/TW200633979A/en
Priority to ARP050105527A priority patent/AR053109A1/en
Priority to IL183665A priority patent/IL183665A/en
Priority to ZA200705159A priority patent/ZA200705159B/en
Priority to NO20073729A priority patent/NO20073729L/en
Priority to HK08105669.1A priority patent/HK1110868A1/en
Priority to AU2010212346A priority patent/AU2010212346B2/en
Priority to US13/018,783 priority patent/US20110136820A1/en
Priority to US13/490,765 priority patent/US20120264762A1/en
Priority to JP2012176224A priority patent/JP2012214507A/en
Priority to US14/025,939 priority patent/US8710224B2/en
Ceased legal-status Critical Current

Links

GB0428327A 2004-12-24 2004-12-24 Method Ceased GB0428327D0 (en)

Priority Applications (27)

Application Number Priority Date Filing Date Title
GB0428327A GB0428327D0 (en) 2004-12-24 2004-12-24 Method
EP05820651A EP1831164A1 (en) 2004-12-24 2005-12-19 Heterocyclic compounds as ccr2b antagonists
BRPI0519288-9A BRPI0519288A2 (en) 2004-12-24 2005-12-19 heterocyclic compounds as ccr2b antagonists
CN200580048668.2A CN101128427B (en) 2004-12-24 2005-12-19 Heterocyclic compounds as ccr2b antagonists
MX2007007428A MX2007007428A (en) 2004-12-24 2005-12-19 Heterocyclic compounds as ccr2b antagonists.
CA2589748A CA2589748C (en) 2004-12-24 2005-12-19 Heterocyclic compounds as ccr2b antagonists
AU2005317928A AU2005317928B2 (en) 2004-12-24 2005-12-19 Heterocyclic compounds as CCR2b antagonists
UAA200706266A UA93489C2 (en) 2004-12-24 2005-12-19 Heterocyclic compounds as ccr2b antagonists
US11/793,606 US7906645B2 (en) 2004-12-24 2005-12-19 Heterocyclic compounds as ccr2b antagonists
PCT/GB2005/004895 WO2006067401A1 (en) 2004-12-24 2005-12-19 Heterocyclic compounds as ccr2b antagonists
RU2007130144/04A RU2423349C2 (en) 2004-12-24 2005-12-19 Heterocyclic compounds as ccr2b antagonists
JP2007547621A JP5118975B2 (en) 2004-12-24 2005-12-19 Heterocyclic compounds as CCR2B antagonists
NZ555770A NZ555770A (en) 2004-12-24 2005-12-19 Heterocyclic piperazine-carboxamide compounds as CCR2B antagonists
KR1020077016875A KR20070091677A (en) 2004-12-24 2005-12-19 Heterocyclic compounds as ccr2b antagonists
MYPI20056171A MY147400A (en) 2004-12-24 2005-12-22 Heterocyclic compounds as ccr2b antagonists
UY29312A UY29312A1 (en) 2004-12-24 2005-12-23 PIPERAZIN-1-CARBOXAMIDAS N, 4, SUBSTITUTES AND THEIR DERIVATIVES, COMPOSITIONS CONTAINING THEM, PREPARATION PROCEDURES AND APPLICATIONS
TW094146424A TW200633979A (en) 2004-12-24 2005-12-23 Method
ARP050105527A AR053109A1 (en) 2004-12-24 2005-12-26 DERIVATIVES OF PIPERIDINE AND PIPERAZINE, A METHOD FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE IN THE PREPARATION OF MEDICINES FOR THE TREATMENT OF DISEASES MEDIATED BY THE CCR2 CHEMIOQUINE RECEPTOR.
IL183665A IL183665A (en) 2004-12-24 2007-06-04 Heterocyclic compounds, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for the treatment of ccr2b mediated conditions
ZA200705159A ZA200705159B (en) 2004-12-24 2007-06-22 Heterocyclic compounds as CCR2B antagonists
NO20073729A NO20073729L (en) 2004-12-24 2007-07-18 Heterocyclic Compounds as CCR2B Antagonists
HK08105669.1A HK1110868A1 (en) 2004-12-24 2008-05-22 Heterocyclic compounds as ccr2b antagonists
AU2010212346A AU2010212346B2 (en) 2004-12-24 2010-08-13 Heterocyclic compounds as CCR2b antagonists
US13/018,783 US20110136820A1 (en) 2004-12-24 2011-02-01 Heterocyclic Compounds as CCR2 Antagonists
US13/490,765 US20120264762A1 (en) 2004-12-24 2012-06-07 Heterocyclic Compounds as CCR2 Antagonists
JP2012176224A JP2012214507A (en) 2004-12-24 2012-08-08 Heterocyclic compound as ccr2b antagonist
US14/025,939 US8710224B2 (en) 2004-12-24 2013-09-13 Heterocyclic compounds as CCR2B antagonists

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0428327A GB0428327D0 (en) 2004-12-24 2004-12-24 Method

Publications (1)

Publication Number Publication Date
GB0428327D0 true GB0428327D0 (en) 2005-02-02

Family

ID=34130900

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0428327A Ceased GB0428327D0 (en) 2004-12-24 2004-12-24 Method

Country Status (4)

Country Link
CN (1) CN101128427B (en)
GB (1) GB0428327D0 (en)
UA (1) UA93489C2 (en)
ZA (1) ZA200705159B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100152197A1 (en) * 2008-12-15 2010-06-17 Astrazeneca Ab (4-tert-butylpiperazin-2-yl)(piperazin-1-yl)methanone-n-carboxamide derivatives
MX2022002720A (en) * 2019-09-05 2022-08-10 Lunan Pharmaceutical Group Corp Magl inhibitor, preparation method therefor and use thereof.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0519449A1 (en) * 1991-06-21 1992-12-23 Boehringer Mannheim Italia S.P.A. 2-Amino-4-aryl thiazoles with antiasthmatic and antiinflammatory activities on the respiratory tract
WO2002038547A1 (en) * 2000-11-13 2002-05-16 Glaxosmithkline Spa Quinoline derivatives as nk-3 and nk-2 antagonists
GB0031088D0 (en) * 2000-12-20 2001-01-31 Smithkline Beecham Plc Medicaments
WO2002079151A1 (en) * 2001-03-29 2002-10-10 Smithkline Beecham P.L.C. 3-substituted indoels or fused pyrroles as antagonists of the chemokine mcp-1 (ccr2b) receptor
WO2004041777A2 (en) * 2002-10-30 2004-05-21 Merck & Co., Inc. Heteroarylpiperidine modulators of chemokine receptor activity
FR2872813B1 (en) * 2004-07-09 2007-01-19 Sanofi Synthelabo 2-CARBAMID-4-PHENYLTHIAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE

Also Published As

Publication number Publication date
CN101128427B (en) 2013-03-27
ZA200705159B (en) 2008-06-25
UA93489C2 (en) 2011-02-25
CN101128427A (en) 2008-02-20

Similar Documents

Publication Publication Date Title
GB0420061D0 (en) Method
GB0402639D0 (en) Method
GB0422733D0 (en) Method
GB0410478D0 (en) Method
GB0418651D0 (en) Method
GB0415009D0 (en) Method
GB0419419D0 (en) Method
GB0422730D0 (en) Method
GB0412659D0 (en) Method
GB0412672D0 (en) Method
GB0420815D0 (en) Method
GB0414787D0 (en) Method
GB0423871D0 (en) Method
GB0419405D0 (en) Method
GB0405751D0 (en) Method
GB0415081D0 (en) Method
GB0428327D0 (en) Method
GB0525618D0 (en) Method
GB0413714D0 (en) Method
GB0406989D0 (en) Method
GB0404931D0 (en) Method
GB0406833D0 (en) Method
GB0422161D0 (en) Method
GB0403586D0 (en) Method
GB0405730D0 (en) Method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)